Appendix A
References
Amonoo, H. L., P. C. Johnson, T. M. Dhawale, L. Traeger, J. Rice, M. W. Lavoie, N. N. Ufere, R. M. Longley, L. E. Harnedy, M. A. Clay, C. E. W. Topping, Z. DeFilipp, Y. A. Chen, and A. El-Jawahri. 2021. Sharing and caring: The impact of social support on quality of life and health outcomes in hematopoietic stem cell transplantation. Cancer 127(8):1260-1265. https://doi.org/10.1002/cncr.33455.
Armenian S. H., M. Xiao, J. B. Teh, B. Lee, H. A. Chang, K. Mascarenhas, S. Lee, A. Iukuridze, J. J. Xie, J. M. Scott, L. W. Jones, F. Wong, S. J. Forman, and R. Nakamura. 2019. Impact of sarcopenia on adverse outcomes after allogeneic hematopoietic cell transplantation. Journal of the National Cancer Institute 111(8):837-844. https://doi.org/10.1093/jnci/djy231.
Arnold, S., D. Ross, C. Sinha, C. Smith, and L. Krishnamurti. 2020. Developing a validated patient-reported outcome instrument to assess financial hardship among hematopoietic cell transplant recipients for sickle cell disease. Quality of Life Research 29 (suppl 1). Netherlands: Springer.
Arora, M., C. L. Sun, K. K. Ness, J. B. Teh, J. Wu, L. Francisco, S. H. Armenian, A. Schad, G. Namdar, A. Bosworth, L. Kuo, D. J. Weisdorf, S. J. Forman, and S. Bhatia. 2016. Physiologic frailty in nonelderly hematopoietic cell transplantation patients: Results from the Bone Marrow Transplant Survivor Study. JAMA Oncology 2(10):1277-1286. https://doi.org/10.1001/jamaoncol.2016.0855.
Arora, M., Y. Chen, J. Wu, L. Hageman, E. Ness, M. Kung, L. Francisco, A. Bosworth, D. J. Weisdorf, S. J. Forman, W. Landier, M. Pamukçuoğlu, S. H. Armenian, F. L. Wong, and S. Bhatia. 2021. Longitudinal trajectory of frailty in blood or marrow transplant survivors: Report from the Blood or Marrow Transplant Survivor Study. Cancer 127(5):794-800. https://doi.org/10.1002/cncr.33313.
Aydillo, T., A. S. Gonzalez-Reiche, S. Aslam, A. van de Guchte, Z. Khan, A. Obla, J. Dutta, H. van Bakel, J. Aberg, A. García-Sastre, G. Shah, T. Hohl, G. PapanicOlaou, M. A. Perales, K. Sepkowitz, N. E. Babady, and M. Kamboj. 2020. Shedding of viable SARSCoV-2 after immunosuppressive therapy for cancer. New England Journal of Medicine 383(26):2586-2588. https://doi.org/10.1056/NEJMc2031670.
Baker, K. S., W. M. Leisenring, P. J. Goodman, R. P. Ermoian, M. E. Flowers, G. Schoch, R. Storb, B. M. Sandmaier, and H. J. Deeg. 2019. Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation. Blood 133(26):2790-2799. https://doi.org/10.1182/blood.2018874115.
Baliousis, M., M. Rennoldson, and J. A. Snowden. 2016. Psychological interventions for distress in adults undergoing haematopoietic stem cell transplantation: A systematic review with meta-analysis. Psychooncology 25(4):400-411. https://doi.org/10.1002/pon.3925.
Basch, E., B. B. Reeve, S. A. Mitchell, S. B. Clauser, L. M. Minasian, A. C. Dueck, T. R. Mendoza, J. Hay, T. M. Atkinson, A. P. Abernethy, D. W. Bruner, C. S. Cleeland, J. A. Sloan, R. Chilukuri, P. Baumgartner, A. Denicoff, D. St Germain, A. M. O’Mara, A. Chen, J. Kelaghan, A. V. Bennett, L. Sit, L. Rogak, A. Barz, D. B. Paul, and D. Schrag. 2014. Development of the National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Journal of the National Cancer Institute 106(9). https://pubmed.ncbi.nlm.nih.gov/25265940 (accessed February 3, 2022).
Battiwalla, M., A. Tichelli, and N. S. Majhail. 2017. Long-term survivorship after hematopoietic cell transplantation: Roadmap for research and care. Biology of Blood and Marrow Transplantation 23(2):184-192.
Beck, J. S., A. T. Beck, and J. B. Jolly. 2001. Beck youth inventory manual: Beck youth inventories of emotional & social impairment. New York: Psychological Corp.
Bele, S., A. Chugh, B. Mohamed, L. Teela, L. Haverman, and M. J. Santana. 2020. Patient-reported outcome measures in routine pediatric clinical care: A systematic review. Frontiers in Pediatrics 28(8):364. https://doi.org/10.3389/fped.2020.00364.
Bevans, M., A. El-Jawahri, D. K. Tierney, L. Wiener, W. A. Wood, F. Hoodin, E. E. Kent, P. B. Jacobsen, S. J. Lee, M. M. Hsieh, E. M. Denzen, and K. L. Syrjala. 2017. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group report. Biology of Blood and Marrow Transplantation 23(4):538-551. https://doi.org/10.1016/j.bbmt.2016.09.011.
Bhatia. S., L. Francisco, A. Carter, C. L. Sun, K. S. Baker, J. G. Gurney, P. B. McGlave, A. Nademanee, M. O’Donnell, N. K. Ramsay, L. L. Robison, D. Snyder, A. Stein, S. J. Forman, and D. J. Weisdorf. 2007. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: Report from the Bone Marrow Transplant Survivor Study. Blood 110(10):3784-3792. https://doi.org/10.1182/blood-2007-03-082933.
Bhatt, N. S., R. Brazauskas, H. R. Tecca, J. Carreras, L. J. Burns, R. Phelan, R. B. Salit, K. L. Syrjala, J.-A. M. Talano, and B. E. Shaw. 2019. Post-transplantation employment status of adult survivors of childhood allogeneic hematopoietic cell transplant: A report from the Center for International Blood and Marrow Transplant Research (CIBMTR). Cancer 125:144-152.
Bhatt, N. S., R. Brazauskas, R. B. Salit, K. Syrjala, S. Bo-Subait, H. Tecca, S. M. Badawy, K. S. Baker, A. Beitinjaneh, N. Bejanyan, M. Byrne, A. Dias, N. Farhadfar, C. O. Freytes, S. Ganguly, S. Hashmi, R. J. Hayashi, S. Hong, Y. Inamoto, K. Jamani, K. A. Kasow, N. Khera, M. M. Krem, H. M. Lazarus, C. J. Lee, S. Lee, N. S. Majhail, A. K. Malone, D. I. Marks, L. W. Mau, S. J. Mayo, L. S. Muffly, S. Nathan, T. Nishihori, K. M. Page, J. Preussler, H. G. Rangarajan, S. J. Rotz, N. Salooja, B. N. Savani, R. Schears, T. Schechter-Finkelstein, G. Schiller, A. J. Shah, A. Sharma, T. Wang, B. Wirk, M. Battiwalla, H. Schoemans, B. Hamilton, D. Buchbinder, R. Phelan, and B. Shaw. 2021. Return to work among young adult survivors of allogeneic hematopoietic cell transplantation in the United States. Transplantation and Cell Therapy 27(8):679. https://doi.org/10.1016/j.jtct.2021.04.013.
Bishop, M. M., B. A. Curbow, S. H. Springer, J. A. Lee, and J. R. Wingard. 2001. Comparison of lasting life changes after cancer and BMT: Perspectives of long-term survivors and spouses. Psychooncology 20(9):926-34. https://doi.org/10.1002/pon.1812.
Bona, K., R. Brazauskas, N. He, L. Lehmann, H. Abdel-Azim, I. A. Ahmed, A. S. Al-Homsi, M. Aljurf, S. D. Arnold, S. M. Badawy, M. Battiwalla, S. Beattie, N. S. Bhatt, J. Dalal, C. E. Dandoy, M. A. Diaz, H. A. Frangoul, C. O. Freytes, S. Ganguly, B. George, D. Gomez-Almaguer, T. Hahn, R. T. Kamble, J. M. Knight, C. F. LeMaistre, J. Law, H. M. Lazarus, N. S. Majhail, R. F. Olsson, J. Preussler, B. N. Savani, R. Schears, S. Seo, A. Sharma, A. Srivastava, A. Steinberg, D. Szwajcer, B. Wirk, A. Yoshimi, N. Khera, W. A. Wood, S. Hashmi, C. N. Duncan, and W. Saber. 2021. Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: A CIBMTR analysis. Blood 137(4):556-568. https://doi.org/10.1182/blood.2020006252. Erratum in: Blood 138(22):2300.
Burger, J. A. 2020. Treatment of chronic lymphocytic leukemia. New England Journal of Medicine 383(5):460-473.
Burns, L. J., B. Abbetti, S. D. Arnold, J. Bender, S. Doughtie, A. El-Jawahiri, G. Gee, T. Hahn, M. M. Horowitz, S. Johnson, M. Juckett, L. Krishnamurit, S. Kullberg, C. F. LeMaistre, A. Loren, N. S. Majhail, E. A. Murphy, D. Rizzo, A. Roche-Green, W. Saber, B. A. Schatz, K. Schmit-Pokorny, B. E. Shaw, K. L. Syrjala, D. K. Tierney, C. Ullrich, D. J. Vanness, W. A. Wood, and E. M. Denzen. 2018. Engaging patients in setting a patient-centered outcomes research agenda in hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation 24(6):1111-1118. https://doi.org/10.1016/j.bbmt.2018.01.029.
De Jong, C. N., E. Meijer, K. Bakunina, E. Nur, M. van Marwijk Kooij, M. R. de Groot, M. van Gelder, J. A. Maertens, J. H. E. Kuball, D. Deeren, B. van der Holt, J. J. Cornelissen, and A. E. C. Broers. 2019. Post-transplantation cyclophosphamide after allogeneic hematopoietic stem cell transplantation: Results of the prospective randomized HOVON-96 trial in recipients of matched related and unrelated donors. Presented at 61st American Society of Hematology (ASH) Annual Meeting and Exposition; December 7-10, 2019; Orlando, FL. Abstract 1.
de Koning, C., S. Prockop, I. van Roessel, N. Kernan, E. Klein, J. Langenhorst, C. Szanto, M. Belderbos, M. Bierings, F. Boulad, D. Bresters, M. Cancio, K. Curran, W. Kollen, R. O’Reilly, A. Scaradavou, B. Spitzer, B. Versluijs, A. Huitema, C. Lindemans, S. Nierkens, and J. J. Boelens. 2021. CD4+ T-cell reconstitution predicts survival outcomes after acute graft-versus-host-disease: A dual-center validation. Blood 137(6):848-855. https://doi.org/10.1182/blood.2020007905.
DeFilipp, Z., F. M. Troschel, D. A. Qualls, S. Li, M. W. Kuklinski, M. E. Kempner, E. Hochberg, Y. B. Chen, A. El-Jawahri, and F. J. Fintelmann. 2018. Evolution of body composition following autologous and allogeneic hematopoietic cell transplantation: Incidence of sarcopenia and association with clinical outcomes. Biology of Blood and Marrow Transplantation 24(8):1741-1747. https://doi.org/10.1016/j.bbmt.2018.02.016.
DeFilipp, Z., A. M. Alousi, J. A. Pidala, P. A. Carpenter, L. E. Onstad, S. Arai, M. Arora, C. S. Cutler, M. E. D. Flowers, C. L. Kitko, G. L. Chen, S. J. Lee, and B. K. Hamilton. 2021. Nonrelapse mortality among patients diagnosed with chronic GVHD: An updated analysis from the Chronic GVHD Consortium. Blood Advances 5(20):4278-4284. https://doi.org/10.1182/bloodadvances.2021004941.
Derogatis, L., and N. Melisaratos. 1983. The Brief Symptom Inventory: An introductory report. Psychological Medicine 13(595-605).
Derrett, S., M. Herdman, L. G. Ngwira, E. Y. Moore, and J. Jelsma. 2021. A new approach to assessing children’s interpretation of severity qualifiers in a multi-attribute utility instrument–the EQ-5D-Y-5L: Development and testing. Patient 14:591-600. https://doi.org/10.1007/s40271-021-00496-1.
D’Souza, A., C. Fretham, S. J. Lee, M. Arora, J. Brunner, S. Chhabra, S. Devine, M. Eapen, M. Hamadani, P. Hari, M. C. Pasquini, W. Perez, R. A. Phelan, M. L. Riches, J. D. Rizzo, W. Saber, B. E. Shaw, S. R. Spellman, P. Steinert, D. J. Weisdorf, and M. M. Horowitz. 2020. Current use of and trends in hematopoietic cell transplantation in the United States. Biology of Blood and Marrow Transplantation 26(8):e177-e182.
DuHamel, K. N., C. E. Mosher, G. Winkel, L. E. Labay, C. Rini, Y. M. Meschian, J. Austin, P.B. Greene, C. R. Lawsin, A. Rusiewicz, C. L. Grosskreutz, L. Isola, C. H. Moskowitz, E. B. Papadopoulos, S. Rowley, E. Scigliano, J. E. Burkhalter, K. E. Hurley, A. R. Bollinger, and W. H. Redd. 2010. Randomized clinical trial of telephone-administered cognitive-behavioral therapy to reduce post-traumatic stress disorder and distress symptoms after hematopoietic stem-cell transplantation. Journal of Clinical Oncology 28(23):3754-3761. https://doi.org/10.1200/JCO.2009.26.8722.
Dunbar, C. E., K. A. High, J. K. Joung, D. B. Kohn, K. Ozawa, and M. Sadelain. 2018. Gene therapy comes of age. Science 359(6372):eaan4672. https://doi.org/10.1126/science.aan4672.
Eapen, M., R. Brazauskas, M. C. Walters, F. Bernaudin, K. Bo-Subait, C. D. Fitzhugh, J. S. Hankins, J. Kanter, J. J. Meerpohl, J. Bolaños-Meade, J. A. Panepinto, D. Rondelli, S. Shenoy, J. Williamson, T. L. Woolford, E. Gluckman, J. E. Wagner, and J. F. Tisdale. 2019. Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: A retrospective multicentre, cohort study. Lancet Haematology 6(11):e585-e596. https://doi.org/10.1016/S23523026(19)30154-1.
Eissa, H. M., L. Lu, M. Baassiri, N. Bhakta, M. J. Ehrhardt, B. M. Triplett, D. M. Green, D. A. Mulrooney, L. L. Robison, M. M. Hudson, and K. K. Ness. 2017. Chronic disease burden and frailty in survivors of childhood HSCT: A report from the St. Jude Lifetime Cohort Study. Blood Advances 1(24):2243-2246. https://doi.org/10.1182/bloodadvances.2017010280.
El-Jawahri, A., T. LeBlanc, H. VanDusen, L. Traeger, J. A. Greer, W. F. Pirl, V. A. Jackson, J. Telles, A. Rhodes, T. R. Spitzer, S. McAfee, Y. A. Chen, S. S. Lee, and J. S. Temel. 2016. Effect of inpatient palliative care on quality of life 2 weeks after hematopoietic stem cell transplantation: A randomized clinical trial. JAMA 316(20):2094-2103. https://doi.org/10.1001/jama.2016.16786.
El-Jawahri, A., L. Traeger, J. A. Greer, H. VanDusen, S. R. Fishman, T. W. LeBlanc, W. F. Pirl, V. A. Jackson, J. Telles, A. Rhodes, Z. Li, T. R. Spitzer, S. McAfee, Y. A. Chen, and J. S. Temel. 2017. Effect of inpatient palliative care during hematopoietic stem-cell transplant on psychological distress 6 months after transplant: Results of a randomized clinical trial. Journal of Clinical Oncology 35(32):3714-3721. https://doi.org/10.1200/JCO.2017.73.2800.
Fatobene, G., B. E. Storer, R. B. Salit, S. J. Lee, P. J. Martin, G. S. Cheng, P. A. Carpenter, G. Balgansuren, E. W. Petersdorf, C. Delaney, B. M. Sandmaier, F. Milano, and M. E. Flowers. 2019. Disability related to chronic graft-versus-host disease after alternative donor hematopoietic cell transplantation. Haematologica 104(4):835-843. https://doi.org/10.3324/haematol.2018.202754.
Fitzhugh, C. D., S. Cordes, T. Taylor, W. Coles, K. Roskom, M. Link, M. M. Hsieh, and J. F. Tisdale. 2017. At least 20% donor myeloid chimerism is necessary to reverse the sickle phenotype after allogeneic HSCT. Blood 130(17):1946-1948. https://doi.org/10.1182/blood-2017-03-772392.
Fiuza-Luces, C., R. J. Simpson, M. Ramírez, A. Lucia, and N. A. Berger. 2016. Physical function and quality of life in patients with chronic GvHD: A summary of preclinical and clinical studies and a call for exercise intervention trials in patients. Bone and Marrow Transplantation 51(1):13-26. https://doi.org/10.1038/bmt.2015.195.
Fried, L. P., C. M. Tangen, J. Walston, A. B. Newman, C. Hirsch, J. Gottdiener, T. Seeman, R. Tracy, W. J. Kop, G. Burke, M. A. McBurnie, and the Cardiovascular Health Study Collaborative Research Group. 2001. Frailty in older adults: Evidence for a phenotype. Journal of Gerontology, Series A: Biological Sciences and Medical Sciences. 56(3):M146-M156. https://doi.org/10.1093/gerona/56.3.m146.
Fries, J. F., B. Bruce, and D. Cella. 2005. The promise of PROMIS: Using item response theory to improve assessment of patient-reported outcomes. Clinical and Experimental Rheumatology 23(5 suppl 39):S53-S57. https://pubmed.ncbi.nlm.nih.gov/16273785 (accessed February 3, 2022).
Goldberg, J. D., J. Zheng, R. Ratan, T. N. Small, K. C. Lai, F. Boulad, H. Castro-Malaspina, S. A. Giralt, A. A. Jakubowski, N. A. Kernan, R. J. O’Reilly, E. B. Papadopoulos, J. W. Young, M. R. van den Brink, G. Heller, and M. A. Perales. 2017. Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplant. Leukemia and Lymphoma 58(8):1859-1871. https://doi.org/10.1080/10428194.2016.1265113.
Greenfield, D. M., N. Salooja, C. Peczynski, S. van der Werf, H. Schoemans, K. Hill, A. Cortelezzi, M. Lupo-Stangellini, Z. N. Özkurt, M. Arat, B. Metzner, P. Turlure, A. Rovo, G. Socié, M. Mohty, A. Nagler, N. Kröger, P. Dreger, M. Labopin, T. S. Han, A. Tichelli, R. Duarte, G. Basak, and J. A. Snowden. 2021. Metabolic syndrome and cardiovascular disease after haematopoietic cell transplantation (HCT) in adults: An EBMT cross-sectional non-interventional study. Bone and Marrow Transplantation 56(11):2820-2825. https://doi.org/10.1038/s41409-021-01414-7.
Hamilton, B. K., B. E. Storer, W. A. Wood, J. A. Pidala, C. S. Cutler, P. J. Martin, G. Chen, M. E. Flowers, and S. J. Lee. 2020. Disability related to chronic graft-versus-host disease. Biology of Blood and Marrow Transplantion 26(4):772-777. https://doi.org/10.1016/j.bbmt.2019.10.019.
Hamilton, B. K., P. Williams, G. Flore, J. Galvin, J. Turnbull, and J. Yu. 2021. Disability associated with chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation. Blood 138(suppl 1):4060. https://doi.org/10.1182/blood-2021-153201.
Hill, L., A. Alousi, P. Kebriaei, R. Mehta, K. Rezvani, and E. Shpall. 2018. New and emerging therapies for acute and chronic graft versus host disease. Therapeutic Advances in Hematology 9(1):21-46. https://doi.org/10.1177/2040620717741860.
Holmqvist, A. S., Y. Chen, J. Wu, K. Battles, R. Bhatia, L. Francisco, L. Hageman, M. Kung, E. Ness, M. Parman, D. Salzman, A. Wadhwa, J. F. Winther, J. Rosenthal, S. J. Forman, D. J. Weisdorf, S. H. Armenian, M. Arora, and S. Bhatia. 2018. Assessment of late mortality risk after allogeneic blood or marrow transplantation performed in childhood. JAMA Oncology 4(12):e182453. https://doi.org/10.1001/jamaoncol.2018.2453.
Inamoto, Y., and S. J. Lee. 2017. Late effects of blood and marrow transplantation. Haematologica 102(4):614-625. https://doi.org/10.3324/haematol.2016.150250.
Jagasia, M. H., H. T. Greinix, M. Arora, K. M. Williams, D. Wolff, E. W. Cowen, J. Palmer, D. Weisdorf, N. S. Treister, G. S. Cheng, H. Kerr, P. Stratton, R. F. Duarte, G. B. McDonald, Y. Inamoto, A. Vigorito, S. Arai, M. B. Datiles, D. Jacobsohn, T. Heller, C. L. Kitko, S. A. Mitchell, P. J. Martin, H. Shulman, R. S. Wu, C. S. Cutler, G. B. Vogelsang, S. J. Lee, S. Z. Pavletic, and M. E. Flowers. 2015. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. Biology of Blood and Marrow Transplantation 21(3):389-401.
Jim, H. S. L., S. K. Sutton, B. J. Small, P. B. Jacobsen, W. A. Wood, J. M. Knight, N. S. Majhail, K. L. Syrjala, and S. J. Lee. 2016. Trajectories of quality of life after hematopoietic cell transplantation: Secondary analysis of Blood and Marrow Transplant Clinical Trials Network 0902 data. Biology of Blood and Marrow Transplantation 22(11):2077-2083. https://doi.org/10.1016/j.bbmt.2016.08.012.
Kanter, J., M. C. Walters, L. Krishnamurti, M. Y. Mapara, J. L. Kwiatkowski, S. RifkinZenenberg, B. Aygun, K. A. Kasow, F. J. Pierciey Jr., M. Bonner, A. Miller, X. Zhang, J. Lynch, D. Kim, J.-A. Ribeil, M. Asmal, S. Goyal, A. A. Thompson, and J. F. Tisdale. 2022. Biologic and clinical efficacy of LentiGlobin for sickle cell disease. New England Journal of Medicine 386:617-628. https://doi.org/10.1056/NEJMoa2117175
Kessler, R. C., C. Barber, A. Beck, P. Berglund, P. D. Cleary, D. McKenas, N. Pronk, G. Simon, P. Stang, T. B. Ustun, and P. Wang. 2003. The World Health Organization Health and Work Performance Questionnaire (HPQ). Journal of Occupational and Environmental Medicine 45(2):156-174.
Khera, N., B. Storer, M. E. Flowers, P. A. Carpenter, Y. Inamoto, B. M. Sandmaier, P. J. Martin, and S. J. Lee. 2012. Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation. Journal of Clinical Oncology 30(1):71-77.
King, A. A., R. C. McKinstry, J. Wu, M. Eapen, R. Abel, T. Varughese, N. Kamani, and S. Shenoy. 2019. Functional and radiologic assessment of the brain after reduced-intensity unrelated donor transplantation for severe sickle cell disease: Blood and Marrow Transplant Clinical Trials Network Study 0601. Biology of Blood and Marrow Transplantation 25(5):e174-e178. https://doi.org/10.1016/j.bbmt.2019.01.008.
Kirchhoff, A. C., W. Leisenring, and K. L. Syrjala. 2010. Prospective predictors of return to work in the 5 years after hematopoietic cell transplantation. Journal of Cancer Survivorship 4(1):33-44. https://doi.org/10.1007/s11764-009-0105-2.
Kroenke, K., R. L. Spitzer, and J. B. Williams. 2001. The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine 16(9):606-613.
Kurosawa, S., T. Yamaguchi, A. Mori, T. Matsuura, T. Mori, M. Tanaka, T. Kondo, Y. Umemoto, H. Goto, S. Yoshioka, S. Machida, T. Sato, Y. Katayama, S. Kato, K. Shono, I. Mizuno, S. I. Fujiwara, A. Kohno, M. Takahashi, and T. Fukuda. 2021. Resignation and return to work in patients receiving allogeneic hematopoietic cell transplantation close up. Journal of Cancer Survivorship. https://doi.org/10.1007/s11764-021-01092-w.
Lee, S. J., D. Fairclough, S. K. Parsons, R. J. Soiffer, D. C. Fisher, R. L. Schlossman, J. H. Antin, and J. C. Weeks. 2001. Recovery after stem-cell transplantation for hematologic diseases. Journal of Clinical Oncology 19(1):242-252. https://doi.org/10.1200/JCO.2001.19.1.242.
Lee, S. J., J. Klein, M. Haagenson, L. A. Baxter-Lowe, D. L. Confer, M. Eapen, M. Fernandez-Vina, N. Flomenberg, M. Horowitz, C. K. Hurley, H. Noreen, M. Oudshoorn, E. Petersdorf, M. Setterholm, S. Spellman, D. Weisdorf, T. M. Williams, and C. Anasetti. 2007. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 110(13):4576-4583. https://doi.org/10.1182/blood-2007-06-097386.
Lee, S. J., T. Seaborn, F. J. Mao, S. C. Massey, N. Q. Luu, M. A. Schubert, J. W. Chien, P. A. Carpenter, C. Moravec, P. J. Martin, and M. E. D. Flowers. 2009. Frequency of abnormal findings detected by comprehensive clinical evaluation at 1 year after allogeneic hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation 15(4):416-420. https://doi.org/10.1016/j.bbmt.2008.12.502.
Lee, S. J., B. Logan, P. Westervelt, C. Cutler, A. Woolfrey, S. P. Khan, E. K. Waller, R. T. Maziarz, J. Wu, B. E. Shaw, D. Confer, M. M. Horowitz, and C. Anasetti. 2016. Comparison of patient-reported outcomes in 5-year survivors who received bone marrow vs peripheral blood unrelated donor transplantation: Long-term follow-up of a randomized clinical trial. JAMA Oncology 2(12):1583-1589.
Lee, S. J., L. Onstad, E. J. Chow, B. E. Shaw, H. S. L. Jim, K. L. Syrjala, K. S. Baker, S. Buckley, and M. E. Flowers. 2018. Patient-reported outcomes and health status associated with chronic graft-versus-host disease. Haematologica 103(9):1535-1541. https://doi.org/10.3324/haematol.2018.192930.
Lerner, D., B. C. Amick 3rd, W. H. Rogers, S. Malspeis, K. Bungay, and D. Cynn. 2001. The Work Limitations Questionnaire. Medical Care 39(1):72-85.
Liang J., S. J. Lee, B. E. Storer, B. E. Shaw, E. J. Chow, M. E. Flowers, E. F. Krakow, M. Bar, K. L. Syrjala, R. B. Salit, C. E. Kurukulasuriya, and H. S. L. Jim. 2019. Rates and risk factors for post-traumatic stress disorder symptomatology among adult hematopoietic cell transplant recipients and their informal caregivers. Biology of Blood and Marrow Transplantation 25(1):145-150. https://doi.org/10.1016/j.bbmt.2018.08.002.
Luznik, L., M. C. Pasquini, B. Logan, R. J. Soiffer, J. Wu, S. M. Devine, N. Geller, S. Giralt, H. E. Heslop, M. M. Horowitz, R. J. Jones, M. R. Litzow, A. Mendizabal, L. Muffly, E. R. Nemecek, L. O’Donnell, R. J. O’Reilly, R. Palencia, J. Schetelig, L. Shune, S. R. Solomon, S. Vasu, V. T. Ho, and M. A. Perales. 2022. Randomized phase III BMT CTN trial of Calcineurin inhibitor-free chronic graft-versus-host disease interventions in myeloablative hematopoietic cell transplantation for hematologic malignancies. Journal of Clinical Oncology 40(4):356-368.
Martin, P. J., G. W. Counts Jr., F. R. Appelbaum, S. J. Lee, J. E. Sanders, H. J. Deeg, M. E. D. Flowers, K. L. Syrjala, J. A. Hansen, R. F. Storb, and B. E. Storer. 2010. Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation. Journal of Clinical Oncology 28(6):1011-1016. https://doi.org/10.1200/JCO.2009.25.6693.
Maude, S. L., T. W. Laetsch, J. Buechner, S. Rives, M. Boyer, H. Bittencourt, P. Bader, M. R. Verneris, H. E. Stefanski, G. D. Myers, M. Qayed, B. De Moerloose, H. Hiramatsu, K. Schlis, K. L. Davis, P. L. Martin, E. R. Nemecek, G. A. Yanik, C. Peters, A. Baruchel, N. Boissel, F. Mechinaud, A. Balduzzi, J. Krueger, C. H. June, B. L. Levine, P. Wood, T. Taran, M. Leung, K. T. Mueller, Y. Zhang, K. Sen, D. Lebwohl, M. A. Pulsipher, and S. A. Grupp. 2018. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia. New England Journal of Medicine 378(5):439-448. https://doi.org/10.1056/NEJMoa1709866.
McCarthy, K. R., L. J. Rennick, S. Nambulli, L. R. Robinson-McCarthy, W. G. Bain, G. Haidar, and W. P. Duprex. 2021. Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape. Science 371(6534):1139-1142. https://doi.org/10.1126/science.abf6950.
Mohananey, D., A. Sarau, R. Kumar, D. Lewandowski, S. M. Abreu-Sosa, S. Nathan, and T. M. Okwuosa. 2021. Role of physical activity and cardiac rehabilitation in patients undergoing hematopoietic stem cell transplantation. JACC: CardioOncol 3(1):17-34. https://doi.org/10.1016/j.jaccao.2021.01.008.
Morrison, E. J., S. L. Ehlers, C. A. Bronars, C. A. Patten, T. A. Brockman, J. R. Cerhan, W. J. Hogan, S. K. Hashmi, and D. A. Gastineau. 2016. Employment status as an indicator of recovery and function one year after hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplant 22(9):1690-1695.
Mupfudze, T. G., C. Meyer, J. M. Preussler, L. W. Mau, Y. T. Bolon, P. Steinert, S. D. Arnold, W. Saber, and L. Krishnamurti. 2021. Hematopoietic cell transplantation outcomes among Medicaid and privately insured patients with sickle cell disease. Transplantation and Cell Therapy 27(8):685.e1-685.e8. https://doi.org/10.1016/j.jtct.2021.04.009.
Nasreddine, Z. S., N. A. Phillips, V. Bédirian, S. Charbonneau, V. Whitehead, I. Collin, J. L. Cummings, and H. Chertkow. 2005. The Montreal Cognitive Assessment, MOCA: A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society 53(4):695-699.
Neelapu, S. S., F. L. Locke, N. L. Bartlett, L. J. Lekakis, D. B. Miklos, C. A. Jacobson, I. Braunschweig, O. O. Oluwole, T. Siddiqi, Y. Lin, J. M. Timmerman, P. J. Stiff, J. W. Friedberg, I. W. Flinn, A. Goy, B. T. Hill, M. R. Smith, A. Deol, U. Farooq, P. McSweeney, J. Munoz, I. Avivi, J. E. Castro, J. R. Westin, J. C. Chavez, A. Ghobadi, K. V. Komanduri, R. Levy, E. D. Jacobsen, T. E. Witzig, P. Reagan, A. Bot, J. Rossi, L. Navale, Y. Jiang, J. Aycock, M. Elias, D. Chang, J. Wiezorek, and W. Y. Go. 2017. Axicabtagene ciloleucel Car T-cell therapy in refractory large B-cell lymphoma. New England Journal of Medicine 377(26):2531-2544.
Ness, K. K., K. R. Krull, K. E. Jones, D. A. Mulrooney, G. T. Armstrong, D. M. Green, W. Chemaitilly, W. A. Smith, C. L. Wilson, C. A. Sklar, K. Shelton, D. K. Srivastava, S. Ali, L. L. Robison, and M. M. Hudson. 2013. Physiologic frailty as a sign of accelerated aging among adult survivors of childhood cancer: A report from the St Jude Lifetime Cohort Study. Journal of Clinical Oncology 31(36):4496-503. https://doi.org/10.1200/JCO.2013.52.2268.
Ness, K. K., and M. D. Wogksch. 2020. Frailty and aging in cancer survivors. Translational Research 221:65-82. https://doi.org/10.1016/j.trsl.2020.03.013. Epub 2020 May 1.
Nørskov, K. H., J. C. Yi, M. L. Crouch, A. S. Fiscalini, M. E. D. Flowers, and K. L. Syrjala. 2021. Social support as a moderator of healthcare adherence and distress in long-term hematopoietic cell transplantation survivors. Journal of Cancer Survivorship 15(6):866-875. https://doi.org/10.1007/s11764-020-00979-4. Erratum in Journal of Cancer 2021 Apr 7.
Park, J. H., I. Rivière, M. Gonen, X. Wang, B. Sénéchal, K. J. Curran, C. Sauter, Y. Wang, B. Santomasso, E. Mead, M. Roshal, P. Maslak, M. Davila, R. J. Brentjens, and M. Sadelain. 2018. Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia. New England Journal of Medicine 378(5):449-459.
Pasquini, M. C., B. Logan, R. J. Jones, A. M. Alousi, F. R. Appelbaum, J. Bolaños-Meade, M. E. D. Flowers, S. Giralt, M. M. Horowitz, D. Jacobsohn, J. Koreth, J. E. Levine, L. Luznik, R. Maziarz, A. Mendizabal, S. Pavletic, M. A. Perales, D. Porter, R. Reshef, D. Weisdorf, and J. H. Antin. 2018. Blood and Marrow Transplant Clinical Trials Network report on the development of novel endpoints and selection of promising approaches for graft-versus-host disease prevention trials. Biology of Blood and Marrow Transplantation 24(6):1274-1280. https://doi.org/10.1016/j.bbmt.2018.01.002. Epub 2018 Jan 8.
Persoon, S., M. J. Kersten, K. van der Weiden, L. M. Buffart, F. Nollet, J. Brug, and M. J. Chinapaw. 2013. Effects of exercise in patients treated with stem cell transplantation for a hematologic malignancy: A systematic review and meta-analysis. Cancer Treatment Review 39(6):682-690.
Phelan, R., M. Arora, and M. Chen. 2020. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR US summary slides. https://www.cibmtr.org/ReferenceCenter/SlidesReports/SummarySlides/pages/index.aspx (accessed February 14, 2022).
Piel, F. B., M. H. Steinberg, and D. C. Rees. 2017. Sickle cell disease. New England Journal of Medicine 376(16):1561-1573.
Prins, A., M. J. Bovin, R. Kimerling, D. G. Kaloupek, B. P. Marx, A. Pless Kaiser, and P. P. Schnurr. 2015. The primary care PTSD screen for DSM-5 (PC-PTSD-5). National Center for PTSD, Veterans Affairs. https://www.ptsd.va.gov/professional/assessment/screens/pc-ptsd.asp (accessed on March 18, 2022).
Prins, M. C., G. van Hinte, N. Koenders, A. L. Rondel, N. Blijlevens, and M. van den Berg. 2021. The effect of exercise and nutrition interventions on physical functioning in patients undergoing haematopoietic stem cell transplantation: A systematic review and meta-analysis. Supportive Care in Cancer 29(11):7111-7126. https://doi.org/10.1007/s00520-021-06334-2.
Reilly, M. C., A. S. Zbrozek, and E. M. Dukes. 1993. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 4(5):353-365.
Riba, M. B., K. A. Donovan, B. Andersen, I. Braun, W. S. Breitbart, B. W. Brewer, L. O. Buchmann, M. M. Clark, M. Collins, C. Corbett, S. Fleishman, S. Garcia, D. B. Greenberg, R. G. F. Handzo, L. Hoofring, C. H. Huang, R. Lally, S. Martin, L. McGuffey, W. Mitchell, L. J. Morrison, M. Pailler, O. Palesh, F. Parnes, J. P. Pazar, L. Ralston, J. Salman, M. M. Shannon-Dudley, A. D. Valentine, N. R. McMillian, and S. D. Darlow. 2019. Distress management, version 3.2019, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network 17(10):1229-1249.
Schuster, S. J., M. R. Bishop, C. S. Tam, E. K. Waller, P. Borchmann, J. P. McGuirk, U. Jäger, S. Jaglowski, C. Andreadis, J. R. Westin, I. Fleury, V. Bachanova, S. R. Foley, P. J. Ho, S. Mielke, J. M. Magenau, H. Holte, S. Pantano, L. B. Pacaud, R. Awasthi, J. Chu, Ö. Anak, G. Salles, and R. T. Maziarz. 2018. Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma. New England Journal of Medicine 380(1):45-56.
Shah, V. K., P. Firmal, A. Alam, D. Ganguly, and S. Chattopadhyay. 2020. Overview of immune response during SARS-CoV-2 infection: Lessons from the past. Frontiers of Immunology 11:1949. https://doi.org/10.3389/fimmu.2020.01949.
Sharma, P., V. Chen, C. M. Fung, J. P. Troost, V. N. Patel, M. Combs, S. Norman, P. Garg, M. Colvin, K. Aaronson, C. J. Sonnenday, J. L. Golob, E. C. Somers, and M. M. Doshi. 2021. COVID-19 outcomes among solid organ transplant recipients: A case-control study. Transplantation 105(1):128-137. https://doi.org/10.1097/TP.0000000000003447.
Shaw, B. E., R. Brazauskas, H. R. Millard, R. Fonstad, K. E. Flynn, A. Abernethy, J. Vogel, C. Petroske, D. Mattila, R. Drexler, S. J. Lee, M. M. Horowitz, and J. D. Rizzo. 2017. Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful. Cancer 123(23):4687-4700. https://doi.org/10.1002/cncr.30936.
Shaw, B. E., K. L. Syrjala, L. E. Onstad, E. J. Chow, M. E. Flowers, H. Jim, K. S. Baker, S. Buckley, D. L. Fairclough, M. M. Horowitz, and S. J. Lee. 2018. PROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivors. Cancer 124(4):841-849. https://doi.org/10.1002/cncr.31089.
Shaw, B. E., A. M. Jimenez-Jimenez, L. J. Burns, B. R. Logan, F. Khimani, B. C. Shaffer, N. N. Shah, A. Mussetter, X. Y. Tang, J. M. McCarty, A. Alavi, N. Farhadfar, K. Jamieson, N. M. Hardy, H. Choe, R. F. Ambinder, C. Anasetti, M. A. Perales, S. R. Spellman, A. Howard, K. V. Komanduri, L. Luznik, M. Norkin, J. A. Pidala, V. Ratanatharathorn, D. L. Confer, S. M. Devine, M. M. Horowitz, and J. Bolaños-Meade. 2021. National Marrow Donor Program-sponsored multicenter, phase II trial of HLA-mismatched unrelated donor bone marrow transplantation using posttransplant cyclophosphamide. Journal of Clinical Oncology 39(18):1971-1982. https://doi.org/10.1200/JCO.20.03502.
Small, T. N., E. B. Papadopoulos, F. Boulad, P. Black, H. Castro-Malaspina, B. H. Childs, N. Collins, A. Gillio, D. George, A. Jakubowski, G. Heller, M. Fazzari, N. Kernan, S. MacKinnon, P. Szabolcs, J. W. Young, and R. J. O’Reilly. 1999. Comparison of immune reconstitution after unrelated and related T-cell–depleted bone marrow transplantation: Effect of patient age and donor leukocyte infusions. Blood 93(2):467-480.
Spitzer, R. L., K. Kroenke, J. B. W. Williams, and B. Löwe. 2006. A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine 166(10):1092-1097.
Sultan, A. M., H. K. Mahmoud, G. M. Fathy, and N. M. Abdelfattah. 2021. The outcome of hematopoietic stem cell transplantation patients with COVID-19 infection. Bone and Marrow Transplantation 56:971-973. https://doi.org/10.1038/s41409-020-01094-9.
Sun, C. L., L. Francisco, T. Kawashima, W. Leisenring, L. L. Robison, K. S. Baker, D. J. Weisdorf, S. J. Forman, and S. Bhatia. 2010. Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: A report from the Bone Marrow Transplant Survivor Study. Blood 116(17):3129-3139; quiz 3377. https://doi.org/10.1182/blood-2009-06- 229369.
Syrjala, K. L., S. L. Langer, J. R. Abrams, B. Storer, J. E. Sanders, M. E. Flowers, and P. J. Martin. 2004. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. JAMA 291(19):2335-2343. https://doi.org/10.1001/jama.291.19.2335.
Syrjala, K. L., S. L. Langer, J. R. Abrams, B. E. Storer, and P. J. Martin. 2005. Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls. Journal of Clinical Oncology 23(27):6596-6606. https://doi.org/10.1200/JCO.2005.12.674.
Syrjala, K. L., S. B. Artherholt, B. F. Kurland, S. L. Langer, S. Roth-Roemer, J. B. Elrod, S. Dikmen. 2011. Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years. Journal of Clinical Oncology 29(17):2397-2404. https://doi.org/10.1200/JCO.2010.33.9119.
Syrjala, K. L., J. C. Yi, and S. L. Langer. 2016. Psychometric properties of the Cancer and Treatment Distress (CTXD) measure in hematopoietic cell transplantation patients. Psychooncology 25(5):529-535. https://doi.org/10.1002/pon.3861.
Syrjala, K. L., S. K. Sutton, H. S. Jim, J. M. Knight, W. A. Wood, S. J. Lee, P. B. Jacobsen, M. H. Abidi, and J. C. Yi. 2017. Cancer and treatment distress psychometric evaluation over time: A BMT CTN 0902 secondary analysis. Cancer 123(8):1416-1423. https://doi.org/10.1002/cncr.30454.
Tamari, R., I. Politikos, D. A. Knorr, S. A. Vardhana, J. C. Young, L. T. Marcello, S. Doddi, S. M. Devlin, L. V. Ramanathan, M. S. Pessin, E. Dunn, M. Palazzo, C. D. Bravo, G. A. Papanicolaou, M. Kamboj, M. A. Perales, D. J. Chung, and G. L. Shah. 2021. Predictors of humoral response to SARS-CoV-2 vaccination after hematopoietic cell transplantation and CAR T-cell therapy. Blood Cancer Discoveries 2(6):577-585. https://doi.org/10.1158/2643-3230.BCD-21-0142.
Tichelli, A., S. Gerull, A. Holbro, A. Buser, G. Nair, M. Medinger, D. Heim, J. P. Halter, and J. R. Passweg. 2017. Inability to work and need for disability pension among long-term survivors of hematopoietic stem cell transplantation. Bone Marrow Transplant 52(10):1436-1442.
Varni, J. W., M. Seid, and C. A. Rode. 1999. The PEDSQL: Measurement model for the pediatric quality of life inventory. Medical Care 37(2):126-139.
Ware, J. E., M. Kosinski, and S. D. Keller. 1996. A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Medical Care 34(3):220-233.
Watkins, B., M. Qayed, C. McCracken, B. Bratrude, K. Betz, Y. Suessmuth, A. Yu, S. Sinclair, S. Furlan, S. Bosinger, V. Tkachev, J. Rhodes, A. G. Tumlin, A. Narayan, K. Cribbin, S. Gillespie, T. A. Gooley, M. C. Pasquini, K. Hebert, U. Kapoor, A. Rogatko, M.
Tighiouart, S. Kim, C. Bresee, S. W. Choi, J. Davis, C. Duncan, R. Giller, M. Grimley, A. C. Harris, D. Jacobsohn, N. Lalefar, M. Norkin, N. Farhadfar, M. A. Pulsipher, S. Shenoy, A. Petrovic, K. R. Schultz, G. A. Yanik, E. K. Waller, J. E. Levine, J. L. Ferrara, B. R. Blazar, A. Langston, J. T. Horan, and L. S. Kean. 2021. Phase II trial of costimulation blockade with abatacept for prevention of acute GVHD. Journal of Clinical Oncology 39(17):1865-1877. https://doi.org/10.1200/JCO.20.01086.
Weathers, F. W., J. A. Huska, and T. M. Keane. 1991. PCL‐C for DSM‐IV. Boston, MA: National Center for PTSD–Behavioral Science Division.
Weathers, F. W., B. T. Litz, T. M. Keane, P. A. Palmieri, B. P. Marx, and P. P. Schnurr. 2013. The PTSD Checklist for DSM-5 (PCL-5). https://www.ptsd.va.gov (accessed February 4, 2022).
Wingard, J. R., N. S. Majhail, R. Brazauskas, Z. Wang, K. A. Sobocinski, D. Jacobsohn, M. L. Sorror, M. M. Horowitz, B. Bolwell, J. D. Rizzo, and G. Socié. 2011. Long-term survival and late deaths after allogeneic hematopoietic cell transplantation. Journal of Clinical Oncology 29(16):2230-2239. https://doi.org/10.1200/JCO.2010.33.7212.
Winterling, J., E. Johansson, L. Wettergren, P. Ljungman, and K. Alexanderson. 2018. Occupational status among adult survivors following allogeneic stem cell transplantation in childhood. European Journal of Cancer Care (English) 27(2):e12808. https://doi.org/10.1111/ecc.12808.
Wolff, D., M. Schleuning, S. von Harsdorf, U. Bacher, A. Gerbitz, M. Stadler, F. Ayuk, A. Kiani, R. Schwerdtfeger, G. B. Vogelsang, G. Kobbe, M. Gramatzki, A. Lawitschka, M. Mohty, S. Z. Pavletic, H. Greinix, and E. Holler. 2011. Consensus conference on clinical practice in chronic GVHD: Second-line treatment of chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation 17(1):1-17.
Wong, F. L., J. B. Teh, L. Atencio, T. Stiller, H. Kim, D. Chanson, S. J. Forman, R. Nakamura, and S. H. Armenian. 2020. Conditional survival, cause-specific mortality, and risk factors of late mortality after allogeneic hematopoietic cell transplantation. Journal of the National Cancer Institute 112(11):1153-1161. https://doi.org/10.1093/jnci/djaa022.
Wood, W. A., A. M. Deal, A. Abernethy, E. Basch, C. Battaglini, Y. H. Kim, J. Whitley, C. Shatten, J. Serody, T. Shea, and B. B. Reeve. 2013. Feasibility of frequent patient-reported outcome surveillance in patients undergoing hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation 19(3):450-459. https://doi.org/10.1016/j.bbmt.2012.11.014.
Wood, W. A., J. Le-Rademacher, K. L. Syrjala, H. Jim, P. B. Jacobsen, J. M. Knight, M. H. Abidi, J. R. Wingard, N. S. Majhail, N. L. Geller, J. D. Rizzo, M. Fei, J. Wu, M. M. Horowitz, and S. J. Lee. 2016. Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902). Cancer 122(1):91-98. https://doi.org/10.1002/cncr.29717.
Wu, N. L., K. R. Krull, K. L. Cushing-Haugen, N. J. Ullrich, N. S. Kadan-Lottick, S. J. Lee, and E. J. Chow. 2021. Long-term neurocognitive and quality of life outcomes in survivors of pediatric hematopoietic cell transplant. Journal of Cancer Survivorship Jun 4. https://doi.org/10.1007/s11764-021-01063-1.
